Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02424838 · ClinicalTrials.gov registry record · NA
22 G - 25 G SINS Trial for Pancreatic Masses
A NA study, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 352
- Enrollment target
NCT02424838: Completed NA study, sponsored by AdventHealth.
NCT02424838 is a NA study that has completed, run by AdventHealth. The registered enrollment target is 352 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02424838, a NA study, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 352 participants
- Enrollment target
Study Summary
After patients have been screened and have signed informed consent, they will be taken to the endoscopy suite. Once the decision has been made to proceed with Fine Needle Aspiration (FNA), the subject will be randomized to 1 of 4 groups: * 22 gauge (G) needle with suction * 25 G needle with suction * 22 G needle without suction * 25 G needle without suction Follow-up Phone Call Phase: Unit staff will call patients 1 week after the procedure to check if patients had any adverse events from the procedure and this will be recorded onto the dataset.
Primary Outcome
The use of suction and a larger gauge needle during EUS-FNA is likely to increase the diagnostic yield of cell block. This may in turn translate to improved diagnosis and hence expedite patient management
Interventions
- PROCEDURE EUS-FNA of pancreatic masses
- DEVICE 22 gauge needle
- DEVICE 25 gauge needle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2014-07-28 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
What the finished NCT02424838 record still lists
NCT02424838 is an interventional study that assigns participants to a tested intervention. The registered 352 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).
The record links to 0 conditions, and to 3 interventions - of which EUS-FNA of pancreatic masses is the first listed.
NCT02424838 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02424838 about?
NCT02424838 is a clinical study titled "22 G - 25 G SINS Trial for Pancreatic Masses". After patients have been screened and have signed informed consent, they will be taken to the endoscopy suite. Once the decision has been made to proceed with Fine Needle Aspiration (FNA), the subject will be randomized to 1 of 4 groups: * 22 gauge (G) needle with suction * 25 G needle with suction...
What is the current status of trial NCT02424838?
This trial is currently completed. It is a NA study. The enrollment target is 352 participants. The study started on 2014-07-28. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT02424838?
The interventions under investigation include: EUS-FNA of pancreatic masses (PROCEDURE), 22 gauge needle (DEVICE), 25 gauge needle (DEVICE).
Who is sponsoring clinical trial NCT02424838?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02424838's enrollment target sits among peer trials
352 292nd of 2000 higher than 1,709 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05811936 · 352 participants · NA
The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads
- NCT06258941 · 352 participants · Phase 1
Classroom Break, Cognition, and Fitness in Elementary School Children
- NCT06269081 · 352 participants · NA
Testing Two Interventions to Improve Health Outcomes and Quality of Life Among Rural Older Adults Living With HIV
- NCT06337292 · 352 participants · Phase 3
Incisional Negative Pressure Wound Therapy to Reduce Infection and Complications in High-Risk Fractures
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI